Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spahn

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Urologia Internationalis|March 11, 2010
Long-term outcome of patients with high-risk prostate cancer following radical prostatectomy and stage-dependent adjuvant androgen deprivationMartin Spahn, Christel Weiss, Pia Bader, et al.
Leukemia & Lymphoma|September 23, 2010
Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomasCora Reiss, Torsten Haneke, Hans-Ulrich Völker, et al.
Cancers|February 5, 2021
Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen TreatmentMarc Wiesehöfer, Elena Dilara Czyrnik, Martin Spahn, et al.
Oncotarget|July 2, 2014
Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migrationAmelie Hailer, Thomas G P Grunewald, Martin Orth, et al.
BMC Cancer|January 17, 2014
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinomaDaniel Vergho, Susanne Kneitz, Andreas Rosenwald, et al.
International Journal of Cancer|July 9, 2009
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrenceMartin Spahn, Susanne Kneitz, Claus-Jürgen Scholz, et al.
Journal of Endourology|May 25, 2002
Evaluation of superficial papillary ablation by endoscopic lasers in an ex vivo kidney modelThomas Knoll, Maurice Stephan Michel, Armando Cueva-Martínez, et al.
Plos One|June 27, 2013
Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancerMaria Schubert, Martin Spahn, Susanne Kneitz, et al.
Urology|August 4, 2009
Testis-sparing surgery versus radical orchiectomy in patients with Leydig cell tumorsAndreas Loeser, Daniel C Vergho, Tiemo Katzenberger, et al.
Current Opinion in Urology|May 25, 2013
Results of surgery for high-risk prostate cancerSteven Joniau, Lorenzo Tosco, Alberto Briganti, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Urologia Internationalis|March 11, 2010
Long-term outcome of patients with high-risk prostate cancer following radical prostatectomy and stage-dependent adjuvant androgen deprivationMartin Spahn, Christel Weiss, Pia Bader, et al.
Leukemia & Lymphoma|September 23, 2010
Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomasCora Reiss, Torsten Haneke, Hans-Ulrich Völker, et al.
Cancers|February 5, 2021
Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen TreatmentMarc Wiesehöfer, Elena Dilara Czyrnik, Martin Spahn, et al.
Oncotarget|July 2, 2014
Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migrationAmelie Hailer, Thomas G P Grunewald, Martin Orth, et al.
BMC Cancer|January 17, 2014
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinomaDaniel Vergho, Susanne Kneitz, Andreas Rosenwald, et al.
International Journal of Cancer|July 9, 2009
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrenceMartin Spahn, Susanne Kneitz, Claus-Jürgen Scholz, et al.
Journal of Endourology|May 25, 2002
Evaluation of superficial papillary ablation by endoscopic lasers in an ex vivo kidney modelThomas Knoll, Maurice Stephan Michel, Armando Cueva-Martínez, et al.
Plos One|June 27, 2013
Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancerMaria Schubert, Martin Spahn, Susanne Kneitz, et al.
Urology|August 4, 2009
Testis-sparing surgery versus radical orchiectomy in patients with Leydig cell tumorsAndreas Loeser, Daniel C Vergho, Tiemo Katzenberger, et al.
Current Opinion in Urology|May 25, 2013
Results of surgery for high-risk prostate cancerSteven Joniau, Lorenzo Tosco, Alberto Briganti, et al.
Pageof 11